Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
Home - The Pharma Times | Pharma & Health Care News Portal
Thursday, April 25, 2024

Ajeenkya D Y Patil Healthcare Awards an Approximate 100 Mn USD...

New Delhi, August 06, 2021: The domestic healthcare player - Ajeenkya D Y Patil Group in a step towards concreting their aspirations to be a...

Biotechnology

Pioneering Real World Study Reveals Successful Tele-ICU Collaboration for Remote Critical Care

BENGALURU, AUGUST 24,2023: In a recent publication that promises to reshape the landscape of healthcare accessibility, a research paper titled "A successful model of a Private-Public...

Conjunctivitis at its peak by NIIMS

New Delhi, August 17, 2023: Conjunctivitis or pink eyes or red eyes is spreading at a fast rate. It is highly infectious and might...

IT & Software Support

Wipro GE Healthcare keen to make diagnostics affordable to all

Wipro GE Healthcare is keen to invest in technologies that are affordable to all.

Terri Bresenhem, President and Chief Executive, GE Healthcare, told reporters here on Wednesday that the company has not only been expanding its presence in India for over two decades now, but investing at least 30 per cent more in recent years. “The investment is both in terms of manpower and strengthening our research and development facility,” she said.

INDIA MANUFACTURE

“We are striving to make healthcare affordable to all. While most medical equipment companies that have established their presence here import close to 80 per cent of their equipment, our import component is less. At GE Healthcare, we design and manufacture 30 per cent of the equipment in India. We have a strong research team, high quality thinkers and innovators here,” she added.

Appointments

Awards

India’s Biggest Pharma Expo in the National Capital

"Indian Pharma Expo 2019" is coming up on 16th, 17th & 18th July at Hall 12A Pragati Maidan, New Delhi. New Delhi, May 28, 2019: India's famous...

Financial Results

Approvals

Clinical Trails

Fujitsu and Tokyo Shinagawa Hospital Embark on Joint Research and Development of AI Technology...

- Fujitsu and Tokyo Shinagawa Hospital to develop an AI-based technology to facilitate the diagnosis of COVID-19 pneumonia - The new AI technology will learn...

Bulk Drug

Health Care

Alternative Medicine

Eye Care

Dr. Agarwal’s Eye Hospital Organises Walkathon on Eye Donation in Bengaluru

Bengaluru , September 7, 2022: Dr. Agarwal's Eye Hospital organized a Walkathon in Bengaluru to raise awareness about eye donation as part of the ongoing National...

Seeing the world differently :Eye Donation Fortnight By Dr. Shibu Varkey- Dr. Shibu Varkey,...

The realm of ophthalmology stands witness to remarkable advancements in medical science that have revolutionized the treatment of visual impairments. However, amidst the array...

Product News

Eisai to Present Data on Oncology Pipeline and Products at ASCO20 Annual Meeting

New Delhi, May 17, 2020: Eisai Co., Ltd. announced today that presentations on a series of abstracts regarding its in-house discovered lenvatinib mesylate (multikinase...

Media Partners

Spotlight

Investments

Packaging

Latest News

Dental Care

India’s leading dental chainoffers new year gift to crooked teeth patients – Clove InvisiBraces

Clove Dental has come up with special offers for its just launched invisible Aligners, a highly innovative alternative to existing metal braces  New Delhi, January...

Hospital Management

Drug Discovery & Development

Drug Discovery Unit (DDU), University of Dundee Licenses GVK BIO Online SAR Database (GOSTAR)

Hyderabad, Andhra Pradesh, India, Wednesday, April 10, 2013 -- (Business Wire India) -- GVK Biosciences (GVK BIO) today announced that it has licensed its Online SAR Database - GOSTAR to the Drug Discovery Unit (DDU) at the University of Dundee. GOSTAR, a manually curated database, has been developed over the span of a decade by a team comprising of more than 200 curators. The product issued globally in various areas such as pharmaceuticals, academics, government sectors, apart from numerous publications that cite the data contained in GOSTAR. GOSTAR contains over 6 million compounds manually curated through the screening of over 2 million patents and 400,000 journals and it also contains more than 18 million quantitative SAR points.

Suppliers

Technology

Companies

Marketing

Our Partners

Machinery & Equipments